The Care for America's Aging Study
Launched by MASSACHUSETTS GENERAL HOSPITAL · Aug 28, 2023
Trial Information
Current as of October 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The Care for America's Aging Study is a research project aimed at improving the lives of older adults who have cognitive impairment or dementia, including Alzheimer’s disease. This study will test whether training home health aides with specialized knowledge about dementia can lead to better management of behavioral symptoms in these patients and enhance their overall quality of life. By focusing on both the individuals with dementia and their caregivers, the study hopes to create a more supportive environment for everyone involved.
To be eligible for this study, participants need to be at least 60 years old, diagnosed with mild cognitive impairment or mild to moderate dementia, and have a discharge plan that includes home care services. Participants must also be able to read English, as all surveys used in the study have been validated in that language. The study is not yet recruiting, but if you or someone you know fits these criteria, it could be an opportunity to receive additional support and training through home health aides.
Gender
ALL
Eligibility criteria
- Inclusion Criteria for Patients:
- • Age 60 years and above
- • Patients in Mass General Brigham healthcare system
- • Mild cognitive impairment or dementia diagnosis of no greater than mild-moderate severity
- • Discharge plan includes referral to home care services
- • As all surveys have been validated in English, we will limit participation to potential participants able to read English.
- Exclusion Criteria for Patients:
- • Discharge to Medicare short-term rehab only
- • Lack of care partner
- • Enrolled in palliative care (projected survival \< 6 months)
- • Clinical severity of dementia that is moderate or greater
- • Any active clinical issues barring safe participation
- • Montreal Cognitive Assessment (MoCA)-blind score below cutoff
- • University of California, San Diego Brief Assessment of Capacity to Consent (UBACC) score below cutoff
About Massachusetts General Hospital
Massachusetts General Hospital (MGH) is a leading academic medical center located in Boston, Massachusetts, renowned for its commitment to advancing medical research and patient care. As a prominent teaching hospital affiliated with Harvard Medical School, MGH plays a pivotal role in clinical trials across a wide range of disciplines, including cardiology, oncology, neurology, and more. The institution is dedicated to fostering innovative research that translates into effective therapies and improved health outcomes. MGH's Clinical Trials Office provides comprehensive support to facilitate the design, implementation, and management of clinical studies, ensuring adherence to the highest ethical standards and regulatory compliance. With a focus on collaboration and patient-centered care, MGH strives to enhance medical knowledge and contribute to the future of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Patients applied
Trial Officials
Olivia I Okereke, MD, MS
Principal Investigator
Massachusetts General Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported